Citadel Advisors’s Biofrontera AG American Depositary Shares BFRA Stock Holding History

Citadel Advisors’s Portfolio BFRA Stock Details BFRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,716	Closed	-$59K	–	15371
2021 Q3	$59K	Sell	10,716 -2,475	-19%	-$14.6K	﹤0.01%	13282
2021 Q2	$85K	Sell	13,191 -10,134	-43%	-$61.8K	﹤0.01%	13045
2021 Q1	$125K	Buy	+23,325	New	+$166K	﹤0.01%	12255

Other funds holding BFRA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's BFRA Position: Q4 2021 in Review

Citadel Advisors sold out of Biofrontera AG American Depositary Shares (BFRA) in Q4 2021, closing a stake of 10,716 shares — an estimated $59K sold.

Citadel Advisors first reported a position in BFRA in Q1 2021 and held it in 3 quarters. The position peaked at $125K in Q1 2021. 3 funds tracked by Wall St. Rank hold BFRA as of Q4 2021.

Citadel Advisors reported no remaining Biofrontera AG American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Citadel Advisors sold 10,716 Biofrontera AG American Depositary Shares shares in Q4 2021, an estimated $59K.
Citadel Advisors first reported a position in Biofrontera AG American Depositary Shares in Q1 2021 and held it in 3 quarters.
Citadel Advisors's Biofrontera AG American Depositary Shares position peaked at $125K in Q1 2021.
3 funds tracked by Wall St. Rank held Biofrontera AG American Depositary Shares as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.